AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06341335 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: paclitaxel
Description: iv, q3w
Study NCT06341335 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: placebo
Description: iv, q3w
Study NCT05176587 — intervention group
Intervention type: OTHER
Intervention: Follow-up of patients undergoing bariatric surgery : integrated pathway
Description: Integrated pathway : multidisciplinary, pre- and post-operative, care course for patients undergoing bariatric surgery
Study NCT05454865 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Jin Si Herbal Tea
Description: Jin Si Herbal Tea 1 pack PO bid for 2 treatment cycles (1 cycle = 3 weeks)
Study NCT05454865 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo 1 1pack PO bid for 1 treatment cycle (1 cycle = 3 weeks) and followed by Jin Si Herbal Tea 1 pack PO bid for the 2nd treatment cycle
Study NCT06071676 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: conventional impression group
Description: Silicon impression material loaded on plastic tray and inserted inside the patient mouth
Study NCT06071676 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: digital impression group
Description: direct scanning was done using intraoral scanner to the female housing of the attachments on position
Study NCT03378414 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intravenous infusion
Description: Intravenous infusion of mesenchymal stem cells: 2 \* 10\^7 cells (30ml)
Study NCT03378414 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intrathecal injection
Description: Intrathecal injection of mesenchymal stem cells: 2 \* 10\^7 cells (1ml)
Study NCT03378414 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: umbilical cord mesenchymal stem cell
Description: Treat patients with umbilical cord mesenchymal stem cell (SCLnow 19#), the dosage based on different procedure
Study NCT05298787 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RLS-0071
Description: RLS-0071 is administered as an IV infusion
Study NCT05582473 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: LST-LC Education
Description: Testing the LST-LC intervention with cultural adaptations integrated through Stage 2 (Adaptation Design). There are 9 modules.~Session 1, we describe the principles underlying the program (safety, hygiene, dignity, comfort, and independence), discuss self-care, and introduce a vignette of caring for a person with dementia, designed to generate conversation around the caregiving role.~Other modules focus on 1) behavioral and 2) communication challenges in the context of dementia; 3) home safety, transfers, and adaptable medical equipment; 4) managing nutrition needs; 5) swallowing challenges; 6) supporting oral hygiene; 7) dealing with incontinence, including preventing and recognizing urinary tract infections; 8) medication management and 9) managing comorbidities including assessing and managing pain
Study NCT05827731 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cesarean section
Description: According to the different outcomes of pregnancy, the patients were divided into natural delivery group and cesarean section group
Study NCT05298787 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saline Placebo
Description: Placebo is administered as an IV infusion
Study NCT05168553 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Revascualrization
Description: Regain pulp vascularity for mature permenant teeth
Study NCT05168553 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional endodontic treatment
Description: Root canal treatment of permenant mature teeth with mechanical preparation and cleaning followed by canal obturation by inert material ( gutta percha)
Study NCT05125731 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parental absence
Description: Parent does not accompany the child during dental treatment
Study NCT05125731 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Parental visual support
Description: The parent does not accompany the child during the dental treatment but watches behind the glass and is seen by the child.
Study NCT05125731 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Parental presence
Description: Parent accompanies the child during dental treatment
Study NCT05680870 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omeprazole
Description: Omeprazole 40 mg 3 times daily for 5 days ..to start 2 days before chemotherapy cycles
Study NCT05387148 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD)
Description: Four 200mg soft gel capsules of Cannabidiol (CBD) will be taken orally daily for a total of 3 days.
Study NCT05387148 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo will be identical in appearance, taste, and composition except for the active ingredient of pure CBD. So, four 200mg soft gel capsules of the placebo will be taken orally daily for a total of 3 days.
Study NCT04771234 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital self-guided CBT-i
Description: A brief version of CBT-i consisting of brief psychoeducation, and the core components sleep restricion and stimulus control, where sleep restriction is based on a simplified sleep diary.
Study NCT05967819 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise Stress
Description: Increased exercise volume
Study NCT05967819 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychosocial Stress
Description: cognitive tasks
Study NCT06391619 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: Study is observational
Study NCT05598151 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HM97662
Description: To evaluate the safety, tolerability, preliminary anti-tumor efficacy, PK and PD of HM97662 in solid tumors
Study NCT05076318 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aminoacid, alanine-infusion
Description: During 3 hours, patient will receive alanine-infusion, while amino-acid and urea will be monitored by blood samples.
Study NCT06354283 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation Exercises
Description: Progressive muscle relaxation techniques were explained to the women from the couples assigned to the Intervention Group by a researcher. In addition to relaxation exercises, deep breathing movements were also explained to the women and progressive muscle relaxation exercises and breathing exercises were performed together. The importance of the exercises and how to do them were explained to the women by the researcher for about 30 minutes and then demonstrated practically for 30 minutes. Each progressive muscle relaxation exercise session lasted approximately 20-25 minutes. The women in the intervention group continued the exercises at home three times a week for four weeks.
Study NCT01132794 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intranasal dexmedetomidine
Description: 1mcg per kg dexmedetomidine given intranasally 45 minutes before operation
Study NCT01132794 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intranasal nasal saline
Study NCT05211544 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: physical therapy modalities and exercise
Description: 30 patient with osteoartritis will do knee strengthening exercise for half an hour a day,3 days a week. This exercise program will continue for 4 weeks. Also they will receive physical therapy modalities during two weeks for ten times. physical therapy modalities include hotpack, tens, ultrasound.
Study NCT05211544 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: kinesio taping and exercise
Description: 30 patient with osteoartritis will do knee strengthening exercise for half an hour a day,3 days a week. This exercise program will continue for 4 weeks. Also they will receive kinesio tape for their knee three times a week for two week
Study NCT05211544 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: exercise
Description: 30 patient with osteoartritis will do knee strengthening exercise for half an hour a day,3 days a week. This exercise program will continue for 4 weeks.
Study NCT06257693 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: enzalutamide
Description: Localized single delivery of the Enolen implant (polymer + enzalutamide) with planned radical prostatectomy
Study NCT05991908 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine, busulfan and melphalan
Description: FLudarabine 150mg/m2 + Busulfan 6.4mg.kg + Mel 140mg/m2
Study NCT05991908 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fludarabine and Busulfan
Description: FLudarabine 150mg/m2 + Busulfan 12.8mg.kg
Study NCT04576741 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: bMBI standard practice
Description: This is a 12-week online mindfulness-based course blended with therapist support via video link using standard practices for Mindfulness-Based Cognitive Therapy (30-minutes/day).
Study NCT06174662 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Music
Description: The patient can decide the music genre (a standard playlist) and receives a noise-cancelling headphone playing the chosen music during mobilization.
Study NCT05132972 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Normoxic Allogenic UCMSC
Description: Allogenic umbilical cord-derived mesenchymal stem cell (UCMSC) from normoxic, culture condition, administered through intravenousinfusion at dose 1x10\^6 cells MSC/kg body weight. The treatment will be administered three times, at three days intervals (day 0, day 3, and day 6)
Study NCT05132972 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Normal saline solution
Description: Sterile saline solution and adminastered through intravenous infusion three times, at three day intervals (day 0, day 3, and day 6)
Study NCT04821648 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RJV001
Description: Subcutaneous injection in the abdomen
Study NCT04821648 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: The placebo formulation has the same shape, color, and qualitative composition as the RJV001 freeze dried powder, with the exception that RJV001 drug substance has been removed. For each cohort group, a placebo will be injected in a single site in the same area as the treatment.
Study NCT05041491 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BREAK
Description: The BREAK intervention is a physical activity regimen.
Study NCT05041491 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: ONE
Description: The ONE intervention is a physical activity regimen.
Study NCT04877834 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexlansoprazole
Description: Dexlansoprazole capsule prepared by SAMI Pharmaceuticals will be administered to this arm.
Study NCT04877834 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexlansoprazole
Description: Dexlansoprazole capsule prepared by Takeda Pharmaceutical Company will be administered to this arm.
Study NCT05677438 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-498 dose#1
Description: oral, once daily, 24 weeks
Study NCT05677438 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-498 dose#2
Description: oral, once daily, 24 weeks
Study NCT05677438 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-498 dose#3
Description: oral, once daily, 24 weeks
Study NCT05677438 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo of CKD-498 dose#1
Description: oral, once daily, 24 weeks
Study NCT05677438 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo of CKD-498 dose#1
Description: oral, once daily, 24 weeks
Study NCT05677438 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo of CKD-498 dose#2
Description: oral, once daily, 24 weeks
Study NCT05677438 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo of CKD-498 dose#2
Description: oral, once daily, 24 weeks
Study NCT05677438 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo of CKD-498 dose#3
Description: oral, once daily, 24 weeks
Study NCT05677438 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo of CKD-498 dose#3
Description: oral, once daily, 24 weeks
Study NCT05692908 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: STI-6129
Description: Four cycles of intravenous infusion of STI-6129 will be given (one infusion every four weeks).
Study NCT04911439 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Low Arousal
Description: This group will see affective images of the International Affective Picture System with low arousal level
Study NCT04911439 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Medium arousal
Description: This group will see affective images of the International Affective Picture System with medium arousal level
Study NCT04911439 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High arousal
Description: This group will see affective images of the International Affective Picture System with high arousal level
Study NCT06176924 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tDCS
Description: tDCS (2mA, 20 min anode placed on DLFPC of left side and cathode on supraorbital cortex of right side) along with relaxation technique.
Study NCT06176924 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Relaxation technique
Description: Relaxation technique
Study NCT06176924 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Relaxation technique
Description: Relaxation technique
Study NCT04852302 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CALM Therapy
Description: The CALM intervention is a brief, individualized psychotherapeutic intervention established to meet an unmet need to address psychological distress and promote well-being in advanced cancer patients.
Study NCT05397223 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1273
Description: Sterile liquid for injection
Study NCT05397223 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1010
Description: Sterile liquid for injection
Study NCT05397223 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1345
Description: Sterile liquid for injection
Study NCT05397223 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: FLUAD®
Description: adjuvanted (MF59), inactivated, quadrivalent seasonal influenza vaccine
Study NCT05397223 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1647
Description: Sterile lyophilized product
Study NCT05790291 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Checklist
Description: the experimental group will practice using the checklist
Study NCT05853523 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Gas ozone
Description: The application of ozone was performed with the HealOzone System X4 (HealOzon, Kavo, Germany). The dentist adapted the silicon cup stricken on the cervical surface of the teeth. The pumping system created the vacuum and the machine applied high dosage of ozone, equal to 32 g/m3, for 30 second.
Study NCT06557980 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: toothpaste
Description: group of patients with hypersensitive areas will use the calcium silicate toothpaste twice per day (morning and bedtime) the toothpaste will be applied uniformly using medium toothbrush to the hypersensitive surfaces for 30seconds. After that, the patient will rinse their mouth with plain water. the other group of patients will use the sodium fluoride toothpaste twice per day (morning and bedtime). The toothpaste will be applied uniformly using a medium toothbrush to the hypersensitive areas for 30 seconds after that the patients will rinse their mouth with plain water
Study NCT04941859 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: acupoint massage and application
Description: Patients in the experimental group were treated with acupoint application combined with acupoint massage on the basis of standard treatment for acute poisoning. When the patient began to launder the stomach, the acupoint was applied to Shenque (umbilical). After the end of the gastric launder, Shenque acupoint and Zusanli diarrhea method (referring to counterclockwise and strong stimulation) were massaged for 15 minutes, and the massage frequency was Q8H.
Study NCT05853523 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Diode laser and desensitized gel
Description: The dentist applied desensitized gel (JW-Desensitizing Gel, Heydent Gmbh, Germany) directly on the cervical zone of the teeth. Subsequently the irradiation was performed with Wiser III (Wiser, Doctor Smile, Italy) in the desensitizing assisted mode (preprogramed protocol). The protocol provides consecutively steps (not in contact) with 20 second of interval, 808 wavelength, and power incrementation, from 0,2 till 0,6 W. radiating the entire desensitize surface second using the black tip (400 micron). The procedure continued maintaining the tip of the laser on contact with the dentine surface making movement of lawn mowing (brushing technique) for 30 second. Then the surface was rinsed, and the irradiation applied again without the gel.
Study NCT05759403 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Cortical excitability using transcranial magnetic stimulation
Description: Transcranial magnetic stimulation (TMS) is a noninvasive neurophysiological technique for assessing human motor cortical function. With TMS, the underlying motor cortex is stimulated by an electric current induced by a transient magnetic field, generated in response to the passage of a large current through the stimulating coil located on the patient's scalp.
Study NCT05399654 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAC-001
Description: TAC-001 is a Toll-like Receptor Agonist Antibody Conjugate (TRAAC)
Study NCT05964101 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab Injection [Opdivo]
Description: Neoadjuvant treatment stage: Nivolumab +Carboplatin AUC+ paclitaxel
Study NCT05244486 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RestoreX 1-6 months (randomized phase)
Description: Study participants are recommended utilize the device for 30-60 minutes, 5-7 days a week starting at 1 month post-prostatectomy and continuing until 6 months.
Study NCT05244486 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: RestoreX 6-9 months (open label phase)
Description: Both the treatment and control arms will be allowed to use the therapy from 6-9 months post-prostatectomy (open label phase). Only straight traction will be used (no counterbending).
Study NCT05244486 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RestoreX 6-9 months (open label phase)
Description: Both the treatment and control arms will be allowed to use the therapy from 6-9 months post-prostatectomy (open label phase). Only straight traction will be used (no counterbending).
Study NCT05106517 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Denosumab
Description: Denosumab 60mg/6 months subcutaneously + placebo iv
Study NCT05106517 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Description: Iv zoledronic acid and placebo /6 months subcutaneously
Study NCT05129124 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: kalifilcon A Daily Disposable Toric LD213001 Contact Lenses
Description: kalifilcon A Daily Disposable Toric LD213001 Contact Lenses at different fittings
Study NCT04808999 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab Injection
Description: 200 mg IV infusion
Study NCT06050148 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Feacal microbial transplantation (FMT)
Description: Feacal microbial transplantation (FMT)
Study NCT06050148 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo transplantation (PT)
Description: Transplantation with coloured 0,9% NaCl-solution
Study NCT05123820 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment period A
Description: Midazolam solution for oral administration. Omeprazole hard capsule for oral administration.
Study NCT05129124 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Commercially available Ultra for Astigmatism Contact Lenses
Description: Commercially available Ultra for Astigmatism Contact Lenses at different fittings
Study NCT05123820 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment period B
Description: ACT-1014-6470 soft capsule for oral administration. Midazolam solution for oral administration. Omeprazole hard capsule for oral administration.
Study NCT05254171 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SBP-101
Description: small molecule polyamine metabolic inhibitor for subcutaneous injection
Study NCT05254171 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Nab-paclitaxel
Description: paclitaxel protein-bound particles for injectable suspension
Study NCT05254171 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel
Description: paclitaxel protein-bound particles for injectable suspension
Study NCT05254171 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Gemcitabine
Description: gemcitabine for injection
Study NCT05254171 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: gemcitabine for injection